Ситаглиптин/Метформин Гриндекс

Ситаглиптин/Метформин Гриндекс combines two active ingredients for type 2 diabetes management. This oral medication supports blood sugar control by enhancing insulin production and reducing glucose production. Suitable for adults with type 2 diabetes when diet and exercise alone are insufficient. Always follow healthcare provider guidance.

Ситаглиптин/Метформин Гриндекс is used to improve blood sugar levels in adults with type 2 diabetes. It combines sitagliptin, which increases insulin release after meals, and metformin, which decreases glucose production in the liver. This combination helps manage hyperglycemia when diet and exercise are not enough. It is not for type 1 diabetes or diabetic ketoacidosis.

Users may notice improved energy levels and reduced symptoms of high blood sugar, such as excessive thirst or frequent urination. Some people experience mild digestive effects like nausea or diarrhea when starting treatment. These effects often lessen over time as the body adjusts. Regular monitoring helps track how the medication is working.

Keep this medication out of reach of children and pets. Store at room temperature away from moisture and heat. Do not use if expired or if the packaging is damaged. Inform your healthcare provider about all current medications and medical conditions before starting. Regular blood sugar checks are recommended during use.

Alcohol may increase the risk of lactic acidosis or low blood sugar when combined with this medication. Certain medications, such as diuretics or corticosteroids, may affect blood sugar levels. CYP3A4 inhibitors or inducers can alter sitagliptin levels in the body. Always review all medications with a healthcare professional before use.